Frazier Life Sciences IX, L.P. - Significant Ownership

Signature - Title
/s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHMLS IX, L.L.C., GP of FHMLS IX, L.P., GP of Frazier Life Sciences IX, L.P.
Location
Seattle, WA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences IX, L.P..

Email me when Frazier Life Sciences IX, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Frazier Life Sciences IX, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MIRM MIRUM PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share 7.4% $274M 3.74M 0% James N. Topper Nov 1, 2025

Schedules 13D/G Reported by Frazier Life Sciences IX, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.